Skip to main content
Other
Response to the FDA Draft Guidance for Industry document: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims (Docket 2006D-0044)
Quantitative Health Sciences Publications and Presentations
  • Jakob B. Bjorner, QualityMetric Inc.
  • Barbara Gandek, QualityMetric Inc.
  • Jason Cole, QualityMetric Inc.
  • Mark Kosinski, QualityMetric Inc.
  • Gene Wallenstein, QualityMetric Inc.
  • Milena Anatchkova, QualityMetric Inc.
  • John E. Ware, Jr., University of Massachusetts Medical School
UMMS Affiliation
Department of Quantitative Health Sciences
Publication Date
12-1-2006
Document Type
Response or Comment
Subjects
Outcome Assessment (Health Care); Product Labeling; Research; Health Care Sector
Source
Bjorner, J. B., Gandek B., Cole, J. C., Kosinski, M., Wallenstein, G. V., Anatchkova, M., and Ware J.E., Jr. Response to the FDA Draft Guidance for Industry document: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims (Docket 2006D-0044). 2006.
Citation Information
Jakob B. Bjorner, Barbara Gandek, Jason Cole, Mark Kosinski, et al.. "Response to the FDA Draft Guidance for Industry document: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims (Docket 2006D-0044)" (2006)
Available at: http://works.bepress.com/john_ware/8/